Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,281 | 7,990 | 4,133 | 5,664 | 6,505 |
| Inventories | 86 | N/A | N/A | N/A | N/A |
| Other current assets | 12 | 12 | 12 | 0 | 12 |
| TOTAL | $6,715 | $8,196 | $4,533 | $6,246 | $7,292 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 48 | 71 | 117 | 150 | 35 |
| TOTAL | $48 | $71 | $117 | $150 | $35 |
| Total Assets | $6,751 | $8,267 | $4,638 | $6,396 | $7,327 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 104 | 104 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,766 | 5,605 | 926 | 1,033 | 1,155 |
| Accrued Expenses | 715 | 861 | 685 | 843 | 964 |
| TOTAL | $6,621 | $6,641 | $1,716 | $2,015 | $2,154 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,000 | 2,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 53 | 0 | 0 | 0 | 0 |
| TOTAL | $2,053 | $2,000 | $N/A | $N/A | $N/A |
| Total Liabilities | $8,674 | $8,641 | $1,716 | $2,015 | $2,154 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 183 | 180 | 171 | 170 | 168 |
| Common Shares | 3 | 3 | 2 | 2 | 2 |
| Retained earnings | -96,617 | -94,488 | -87,521 | -85,730 | -84,312 |
| TOTAL | $-1,923 | $-374 | $2,922 | $4,381 | $5,173 |
| Total Liabilities And Equity | $6,751 | $8,267 | $4,638 | $6,396 | $7,327 |